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The origin of idiopathic diseases is still poorly understood. The latent early-life 
associated regulation (LEARn) model unites environmental exposures and gene 
expression while providing a mechanistic underpinning for later-occurring disorders. 
We propose that this process can occur across generations via transgenerational LEARn 
(tLEARn). In tLEARn, each person is a ‘unit’ accumulating preclinical or subclinical ‘hits’ 
as in the original LEARn model. These changes can then be epigenomically passed 
along to offspring. Transgenerational accumulation of ‘hits’ determines a sporadic 
disease state. Few significant transgenerational hits would accompany conception 
or gestation of most people, but these may suffice to ‘prime’ someone to respond 
to later-life hits. Hits need not produce symptoms or microphenotypes to have a 
transgenerational effect. Testing tLEARn requires longitudinal approaches. A recently 
proposed longitudinal epigenome/envirome-wide association study would unite 
genetic sequence, epigenomic markers, environmental exposures, patient personal 
history taken at multiple time points and family history.
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Published online: 7 March 2016
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Background
Recent human genome research, accompa-
nied by ever-increasing technological develop-
ments, continues to significantly enhance our 
understanding of human diseases in terms of 
etiology, diagnosis, drug response and novel 
treatment avenues. Diseases are often het-
erogeneous (several diseases overlapping as 
one) and multigenic, meaning disease pheno-
type (symptoms) can be caused by multiple 
genes/mutations, although each individual 
might or might not have one main indepen-
dently causal rare variant. Exclusive use of 
homogeneous populations (e.g., Canadian 
founder, Icelandic and Utah cohorts) in stud-
ies will not yield clinically relevant biomarkers 
applicable to the population at large.
In the present Special Report, we will 
briefly mention the advances and limits 
of current genetic research and technol-
ogy and then focus onto gene–environment 
interaction that would support and expand 
various genetic models to explain human 
diseases. Our premise is that sporadic cases 
of Alzheimer’s disease (AD), Parkinson’s dis-
ease (PD), suicide and other disorders display 
well-established environmental associations. 
The latent early-life associated regulation 
(LEARn) model integrates early-life events, 
environmental exposures and gene expres-
sion while providing a mechanism for disor-
ders occurring later in the life of an organ-
ism. Here, we propose that this process can 
also occur across generations via transgen-
erational LEARn (tLEARn). We provide 
evidence from different research studies in 
favor of the proposed concept, tLEARn, 
which uniquely interconnects environmental 
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influence upon genes via epigenetic modification due 
to early-life ‘hits’, with the epigenomic record of such 
‘hits’ being passed along to further generations.
Genomic variations: small variants, copy 
number variants & rare variants do not add 
up to explain the cases of sporadic diseases
Human genomes are usually considered a spectrum of 
‘normal’ variation within an ethnically diverse popu-
lation. A small fraction of variants can be identified, 
which may be unique to a disease or drug profile. Per-
sonalized medicine would be based on defining genetic 
subgroups by rare genetic variants. According to the 
common variant hypothesis, which postulates that 
gene variation within the human founding population 
underlies the predisposition to heritable diseases, most 
SNPs have little clinical value.
At best, most SNPs discovered in genome-wide asso-
ciation studies (GWAS) associate with slight increases 
in disease incidence and are often described as ‘predis-
position’, ‘risk’ or ‘susceptibility’ factors. The research 
value of these changes points toward biochemical path-
ways of interest, particularly to discover intervention 
targets that are perturbed by environmental factors 
under the reasonable presumption that a genetic risk 
mimics the effect of environmental damage upon that 
gene’s normal expression. This has been the case in the 
use of statins in response to genetic discoveries regard-
ing HMG reductase to reduce low-density lipoprotein 
cholesterol [1]. Furthermore, cumulative effects of small 
genetic changes may produce great overall variability 
in psychiatric conditions like bipolar disorder [2].
Genome-wide biomarker discovery platforms sys-
tematically reveal rare genetic variants that could be 
used in combination to differentiate responders from 
nonresponders and to predict serious adverse events in 
drug development trials by shared biochemical com-
plexes in which these genes participate. Furthermore, 
while copy number variants (CNVs) and other struc-
tural variants make a major contribution to genetic 
variation, they are frequently found in both healthy 
people and those with sporadic diseases, such as autism 
spectrum disorder (ASD), schizophrenia and PD. 
Recently, the importance of de novo (occurring for the 
first time in an individual) mutation in disease etiology 
has been recognized [3,4]. Rare genetic variants have 
recently been found to play a larger role in diseases 
than previously known – up to 7% of cases of bipolar 
disorder, schizophrenia or ASD [5]. This could poten-
tially be of aid to millions of people, depending on 
overall disease prevalence. On the other hand, a model 
that explains up to 7% of cases still does not explain 
over 90% of cases, and in some situations, such as ASD 
with IQ ≥100, de novo mutation has no correlation [3].
Genetic models can be greatly supported and 
expanded by explicit mechanistic explanations of 
gene–environment interaction. For example, well-
established environmental associations have been 
found for PD [6], AD [7,8], suicide [9] and other dis-
orders [10,11]. A model is needed that incorporate the 
role of environment, including both early and later-life 
exposures, the resultant ‘somatic epitypes’, their effects 
on adult-life disorders and potentially beyond a single 
lifespan. Such a model would provide a unique con-
cept, tLEARn – the major focus of the present Special 
Report. This concept will interconnect environmental 
influence upon genes via epigenetic modification due 
to early-life hits with the epigenomic record of such 
hits being passed along to further generations.
Genetic variation on its own does not 
explain all pathogenesis of ‘sporadic’ 
disorders
The origin, pathogenesis and trajectory of idiopathic 
or sporadic diseases, including some forms of neurode-
generative disorders, that do not follow the Mendelian 
law of inheritance have attracted increasing attention 
in recent years, particularly in developing models of 
polygenic inheritance, endophenotypes, de novo muta-
tion and others. Large-scale genomic association stud-
ies have pointed toward pathway disruptions that could 
occur at any point, not just single gene [12]. Neverthe-
less, in some disorders with known genetic compo-
nents, such as AD, cases that can be explained solely 
by genetic mutation are a minor fraction. Those forms 
of AD that are autosomally inherited and traceable to 
specific DNA variations account for no more than 10% 
of cases [13]. Primary DNA sequence variation certainly 
accounts for substantial proportions of variance for 
some diseases, but environment and gene × environment 
interaction can account for a greater proportion in oth-
ers. Epigenetics would be no panacea. The epigenetic 
approach would be an additional tool to be used when 
appropriate for a specific disorder.
There is an important role played by epigenomic 
factors in conditions as diverse as AD [14–16], PD [16–18], 
ASD, schizophrenia and even suicide [19–21]. The field 
has determined epigenetic changes for specific genes, 
such as SHANK3 [22], brain region-specific epigenetic 
alterations [23] and several differences in the epigenome 
between monozygotic (MZ) twins discordant for 
ASD [24]. This epigenomic discordance is of particular 
interest because there is not a simple epigenome-wide 
difference between ASD and non-ASD MZ twins. 
Instead, differential methylation was clustered around 
specific loci, including NLGN2, SNRPN and ATP-sen-
sitive inward rectifier potassium channel 10 (KCNJ10), 
among others. In addition, further site-specific methy-
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lome differences were found to depend upon whether 
ASD was familial or sporadic [25–27]. In AD, the epig-
enomic evidence is as direct as brain cortical neuron-
specific differences in gene promotor methylation in 
twins discordant for AD [28] and overall hypomethyl-
ation and hypohydroxymethylation of DNA from hip-
pocampus of AD patients versus non-AD subjects [29]. 
However, epigenetic effects on neuropsychiatric issues 
are not simply a matter of insufficient DNA meth-
ylation. In fact, brains from victims of suicides show 
increased methylation [19,21]. Bipolar disorder is also 
associated with increased DNA methylation and gene 
repression, including KCNQ3 [30–32]. BDNF was sub-
ject to hypermethylation and downregulation in major 
depressive disorder [33,34].
However, DNA modification is not the sole form 
of epigenomic marker. The other major epigenomic 
marker is the modification of histones, including acet-
ylation, phosphorylation and ubiquitination, among 
others [35]. Aberrant histone acetylation is associ-
ated with AD [14] and post-traumatic stress disorder 
(PTSD) [7]. Exposure to the pesticides paraquat and 
dieldrin are associated with PD [36]. Dieldrin and other 
pesticides also induce hyperacetylation of histones H3 
and/or H4 [37,38], and such induced hyperacetylation 
is strongly associated with dopaminergic neurotoxic-
ity [6,39]. Of particular interest, psychiatric (antidepres-
sant) effects have been noted for epigenetic drugs, par-
ticularly the histone deacetylase inhibitor MS-275 [40]. 
In addition, nicotine, heroin, methamphetamine, 
cocaine and ethanol each induce chromatin-altering 
modifications of histones when administered through 
methods typical of their abuse. These alterations are 
followed by changes in multiple pathways in brain 
reward circuitry [41].
Epigenomic contributions to neurobiological disor-
ders may actually reach across generations. For exam-
ple, an association has been found between paternal 
age at conception and risk for ASD and schizophre-
nia in offspring [42–44]. While one interpretation has 
been an accumulation of germ-line DNA mutations, 
an alternate mechanism would be an accumulation 
of environmentally induced epigenomic changes. The 
connection between environmental stress and epig-
enomic changes is well known [45–47]. The idea that 
prenatal and perinatal conditions influence health in 
childhood and later life has been long established. 
That the life of the father may also exert an influence 
adds another level of complexity.
A molecule that has been getting a good deal of 
attention in the literature is miRNA, which is short, 
noncoding RNA capable of modulating protein 
expression by acting as a set of specific recognition 
site ‘sockets’ in the RISC translation regulation 
complex, primarily targeting the 3’UTR of associ-
ated mRNA [48]. Modulation of various epigenetic 
markers requires miRNA activity in Arabidopsis [49] 
and has been shown to exist in mouse models [50] 
and clinical samples [51]. miRNA-mediated meth-
ylation [49,52–54], acetylation [50] and ribosylation [55] 
have been reported in the literature – primarily 
related to tumorigenesis. Thus, while miRNA plays 
‘a role’ in epigenetics, such a role would be, therefore, 
analogous to DNMT or HDAC or proteins that regu-
late DNMT or HDAC and does not grant miRNA a 
special status as an epigenetic agent. Environmental 
factors such as cigarette smoke [56], physical activ-
ity [57], metal exposure [58] and infection [59] can reg-
ulate miRNA levels. The miRNA genes can be under 
the influence of epigenetic modification [60–62]. We 
do not claim that miRNA is specifically inherited 
as an epigenetic marker or any sort of particularly 
epigenetic factor, any more than any other DNA 
transcription product.
LEARn unites environmental exposures 
& gene expression while providing a 
mechanistic underpinning for later-occurring 
disorders
The LEARn model encompasses environment–
genome interaction in the etiology of sporadic neu-
ropsychiatric disorders. Such disorders include, but 
are not limited to ASD, affective disorders, neuro-
degenerative disorders such as AD and PD, and oth-
ers. The model connects environmental influence 
to biological outcomes through the mechanism of 
altering biochemical (such as epigenetic) markers. In 
short, LEARn posits that, for many sporadic disor-
ders, the body accumulates ‘hits’ (that may include 
some genetic predispositions), but no single hit is 
sufficient to cause disease, instead, each is individu-
ally dormant. Many hits are of environmental origin 
and are ‘recorded’ and maintained in the organism 
through epigenomic markers (Figure 1). If a sufficient 
number of ‘correct’ hits occur before a critical devel-
opmental/aging threshold, the organism will develop 
the corresponding disorder [63,64]. The critical ele-
ments of the LEARn model are latency and that the 
latent hits can affect the organism even if the specific 
(causative) stimulus has long since been cleared, since 
the immediate biochemical effect is a persistent epig-
enomic alteration. LEARn-mediated disorders are not 
immediate acute products of a malign stimulus ASD, 
AD, PD or others would not appear until a critical 
threshold of hits is reached, and this critical threshold 
may include normal biological stages of development, 
maturation and aging. This is similar to the ‘n-hit’ 
model of oncology [63,65].
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Figure 1. The latent early-life associated regulation model. LEARn explains idiopathic disorders on the basis of accumulation of ‘hits’ 
through an organism’s lifespan. Hits can be environmental, genetic or epigenetic. (A) Genetic pathway: a ‘purely’ genetic disorder, such 
as Alzheimer’s disease (AD) due to APP KM670/671NL (Swedish) mutation. AD-associated genes’ DNA sequence variant determines 
disease state in an autosomal dominant fashion (‘familial’ AD/FAD). (B) Development of diseasevia LEARn pathway. A primary ‘hit’ 
between conception and a critical developmental threshold instills a latent epigenetic change. If this is followed by subsequent ‘hits’ 
later in life, accumulated risk factor effects reach clinical disease state as in the sporadic AD. (C) LEARn pathway across generations: 
t-LEARn. Similar to LEARn progression except that the original ‘hit’ has occurred in an earlier generation and been transmitted 
asymptomatically by epigenetic inheritance. (D) Remediation pathway or ‘Averted’ LEARn. Given that many epigenetic marker states 
can be altered by environmental factors, including nutrition and drugs, the possibility exists that one or more of the effects of a given 
‘hit’ may be reversed by these means. Should this occur,accumulated effects will not reach clinical disease.  
LEARn: Latent early-life associated regulation; tLEARn: Transgenerational latent early-life associated regulation.
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A model uniting environment, organism  
& generations: tLEARn
The original LEARn model explicitly unites ‘environ-
ment’, described in whole or part as ‘envirome’ [66,67], 
‘exposome’ [67,68], and so on, and the organism ‘as an 
information network’ [63]. The envirome is essentially 
‘anything outside the organism that can influence 
its function through epigenetic changes’. It includes 
sociocultural effects (poverty, education and status) 
and historical events (warfare and economic cycles), 
as well as nutrition and exposure to toxins, radiation 
or pathogens (sometimes called the exposome), and 
even elements of development and aging, which are 
not entirely governed by internal programs (Figure 2). 
From therapeutic and preventative standpoints, many 
aspects of the envirome are highly influential but of 
secondary usefulness, usually because of presumed 
difficulty inherent in controlling those particular ele-
ments. Two parts of the envirome that receive a great 
deal of medical attention are exposures to ‘toxic’ mate-
www.futuremedicine.com 377future science group
 Transgenerational latent early-life associated regulation unites environment & genetics across generations    Special Report
rials (including radiation) and nutrition. In particu-
lar, nutrition holds out potentially powerful ‘handles’ 
because it is one factor that could hypothetically be 
tailored and managed at the individual level.
An organism in interaction with the envirome 
(Figure 3) can be seen to exist on two levels. Physically, 
it is the information coding and transmitting mol-
ecules within an organism. These include nucleic acids 
(DNA and RNA) and the chemical modifications 
made to them (e.g., methylation and oxidation); the 
histones and their modifications (e.g., acetylation and 
phosphorylation); the proteome, which has its own 
primary amino acid sequence chemical modifications; 
and spatial (re)organization of any or all of these bio-
chemical elements. An organism can also be modeled 
as an information network that ‘resides’ in the ‘media’ 
of the various molecules (and their 3D structures), 
and this changes over time, a highly dynamic sys-
tem that includes both relatively stable (chromosomal 
DNA) and ephemeral (RNA, proteins and epigenetic 
markers) physical elements, together with factors that 
are not physical objects, but are how the objects are 
arranged at a given moment. It is constantly under 
modification in response to environmental influences. 
An organism can also be seen as the substrate of the 
envirome [66,67]. In addition, each individual organ-
ism (person) can exert influence to a greater or lesser 
degree upon its individual envirome and larger shared 
enviromes, thus influencing other organisms (people). 
Within LEARn, it is an environmental activity upon 
the organism throughout the lifespan that gives rise 
to idiopathic disorders. Transgenerational (tLEARn) 
extends this concept across generations.
 Nongenetic ‘intergenerational transmission’ of traits 
such as ‘harsh parenting’ [69] and domestic violence [70] 
is documented through purely behavioral explanations, 
as have behavioral prevention [71] or mitigation [72,73] 
of such intergenerational social etiology. Nevertheless, 
excesses of behaviorist presumptions and haste to draw 
simple environmental connections have, in the past, 
given rise to now thoroughly discredited claims, such 
as the ‘refrigerator mother’ etiology of ASD [74], the 
‘aluminum hypothesis’ of AD [75] or the ‘schizophreno-
genic mother’ of schizophrenia [76], among many other 
discarded overly enthusiastic environmental hypothe-
ses. The failure of such discarded hypotheses has helped 
give rise to a greater caution with regard to any type of 
‘intergenerational transmission’ of specific disorders (as 
opposed to specific behaviors) that does not rely entirely 
or primarily upon strict genetic inheritance.
The heritability of genetic conditions and risks is 
not currently questioned. It is not asked if it is pos-
sible for traits or conditions to be inherited, only to 
what degree a trait is heritable. Under the classic ‘cen-
tral dogma’, that environmental influences could be 
inherited beyond those that manage to change germline 
DNA was unthinkable. Recent work has since intro-
duced more flexibility in so-called purely biological 
traits. For example, glucose intolerance can be induced 
by neonatal overfeeding. This intolerance does not alter 
Figure 2. The envirome. The envirome is essentially everything external to an organism, including, but not 
limited to nutritional factors (malnutrition vs nutrition); sociocultural and historical factors, such as economic 
and social status, famine and warfare; exposure to ‘chemicals’ and radiation; and the effects of existing through 
time (development and aging). Nutrition and exposure to ‘chemicals’ and radiation can be seen as a general 
‘exposome’. Each of these can influence the others to some degree. Sociocultural factors exert very strong effects 
on the exposome, particularly in nutrition, but also in providing protection (or lack) against hazardous chemicals.
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the DNA sequence, but it can be inherited [77]. Other 
specific instances of nongenetic inheritance of induced 
traits include paternal nutrition altering gene expression 
and health of offspring, particularly in adipose and pan-
creatic islet tissues and in expression of metabolic genes 
in general [78,79]. The CNS does not have a privileged 
immunity from nongenetic heritable alterations. Cer-
tain stress pathologies and responses have turned out 
to be epigenetic in nature and these changes are heri-
table [80,81]. Of particular interest, changes in brain func-
tion can be due to transgenerational epigenetic transmis-
sion [82], including neurobiological pathology [83–85] and 
‘behavioral’ traits, such as aversion to acetophenone [86]. 
In ASD, for example, low paternal folate in diet [87], 
paternal age [42,88], grand paternal age [89] and paternal 
obesity but not maternal obesity [90] contribute to risk 
for ASD. While an argument may be made that effects 
such as grandpaternal age might be a genetic trait in that 
it might reflect a genetic propensity to reproduce later in 
life, linked to social traits common to ASD, factors such 
as paternal folate levels in diet would be more difficult 
to casually dismiss as ‘genetic’. More work needs to be 
done to determine specific genetic/epigenetic/combined 
mechanisms of these intergenerational observations.
Figure 3. The organism as an information network. An organism includes multiple ‘information-containing 
and transmitting systems and molecules’, some of which may be inheritable. Broadly speaking, it can be seen 
as an interlocking network that includes the chromosomal and mitochondrial genomes (encoded by primary 
DNA sequences – mitochondrial not shown for reasons of space). The DNA of the genome plays host to some 
of the molecules that encode the epigenome. The epigenome consists of both modifications to individual DNA 
bases (usually cytosine or guanine) and modifications of the histone complex of the nucleosome (DNA omitted 
from histone complex diagram). Histone and DNA base modification can affect each other. Likewise DNA base 
modification can result in changes in the DNA primary sequence. The epigenome and genome together contribute 
to chromatin structure, and changes in chromatin structure can alter the likelihood of epigenomic modifications. 
Chromatin forms the basis for the RNAsome, which includes mRNA and regulatory molecules such as miRNA. 
The regulatory RNAs modify the processing of other RNAs, such as mRNA, and mRNA forms the template for 
translation to peptide primary sequences, which contribute heavily to the proteosome. The proteosome, itself, 
can modify any or all other levels, therein. The environment can, additionally, act upon any or all levels of the 
network, as well.
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The paternal connection is particularly interesting 
because maternal conditions could influence ASD 
risk through well-known pre/perinatal pathways and 
not nongenetic inheritance. The majority of work 
relating intergenerational nongenetic effects to a neu-
ropsychiatric disorder has been in ASD. It has been 
the presumption that the important environmental 
effects in late-life disorders such as PD and AD occur 
within the patient’s own lifetime. Likewise, little spe-
cifically intergenerational epigenomic work has been 
performed in earlier-manifesting conditions such as 
schizophrenia or major depressive disorder. None-
theless, some potential connections have been drawn 
for schizophrenia [91], depression and glucocorticoid 
sensitivity [92], and PD [93].
In short, tLEARn treats each person as a ‘unit’ 
that can accumulate preclinical or subclinical ‘hits’ 
as described in the original LEARn model [63] and 
these changes can then be passed along to offspring 
along with purely genetic (DNA primary sequence) 
changes. It is the transgenerational accumulation of 
hits that ultimately determines a sporadic disease 
state. For many people, few, if any, significant trans-
generational hits would accompany their conception 
or gestation. For conditions that develop late in life, 
transgenerational effects are likely to be swamped by 
lifetime effects. LEARn is not so much replaced by as 
continued by tLEARn. Specifically, two people may 
undergo a set of potentially transmissible hits in their 
lifetimes. Neither of them accumulates enough hits 
and/or their hits do not accumulate before a critical 
pathogenic developmental cutoff. However, they are 
passed along through epigenomic inheritance. The 
child of these two people may thus have ‘preaccu-
mulated’ sufficient hits to be at significant risk for a 
disorder (Figure 4). It must be stressed that the hits 
need not produce symptoms or microphenotypes in 
either parent to have a transgenerational effect. For 
example, epigenomic alterations that could direct the 
processing of the Alzheimer’s associated amyloid-β 
precursor protein (APP) away from the Alzheimer’s 
related amyloidogenic path and toward the ‘ana-
bolic’ or α-processing pathway could actually be 
neuroprotective in adulthood. However, this spe-
cific instance is even more complex. Evidence exists 
that the anabolic pathway, in excess, may contrib-
ute to autism in early life. Specifically, the sAPPα 
product of the nonamyloidogenic processing of APP 
is neuroprotective and neuroproliferative [94,95]. Sig-
nificantly higher levels of sAPPα have been reported 
in samples from autistic children versus nonautistic 
children [96,97], and particularly high APP levels may 
particularly correlate with increased aggression in 
autistic subjects [98].
Evidence for intergenerational transmission 
of traits via epigenetics
Prenatal exposure to dangerous chemicals and toxins 
can produce disease or increase the chance of disease in 
the fetus. How these changes may persist over genera-
tions has yet to be fully elucidated. Prenatal exposure 
to vinclozolin, a pesticide, can lead to impaired fer-
tility in the F3 generation of the patriline [99]. How-
ever, further work has proved less clear-cut, and the 
original result has been both confirmed and failed 
to confirm [100,101]. Nevertheless, similar generational 
effects have also been observed after exposure to jet 
fuels, plastics, and other environmental toxins during 
gestation. These exposures seem to induce permanent 
epigenetic changes in the germline, and these heritable 
changes lead to adult-onset disease in subsequent gen-
erations without any further exposure to the insult. 
What is particularly interesting is that this process 
can apply to behavioral disorders, such as addiction 
and resistance to addiction [102–104]. Paternal cocaine 
use in mice prior to having offspring alters expression 
of DNA methyltransferases (DNMT ) 1 and 3a in the 
seminiferous tubules and may lead to alterations in 
development of female offspring [105]. Such alteration 
of DNMT levels may be a means of transgenerational 
epigenetics.
Generational transmission of traits leading to con-
ditions related to obesity and metabolic disease has 
some evidentiary support but is not conclusively dem-
onstrated [106]. Alternate scenarios include environ-
mental exposure altering developing germ cells within 
the developing fetus that are not manifest as epiphe-
notypes in F1 generation and effects induced into the 
fetus itself, which would be transmitted to the germ-
line, affecting the next generation [107]. Recent evi-
dence from mouse studies has shown that exposure of 
parents to environmental factors can have a profound 
effect on the changes in insulin sensitivity seen in 
Type 2 diabetes in offspring [108]. Generational effects 
have been seen in animal studies during which mice 
are reexposed to environmental stressors through-
out several generations. Epigenetic models of obesity 
and the metabolic syndrome propose a programmed 
dysregulation of body weight in mice [109].
The experiences of one generation can seemingly 
alter the behavior of the subsequent offspring. The 
experience of maternal separation during early develop-
ment altered DNA methylation levels in the brains and 
sperm of offspring and grandoffspring [110]. It has also 
been shown that there is a period of time during early 
gestation when stressors upon the dam, such as 36 h 
constant light, 15 min of predator odor, novel objects 
in the cage, overnight 5 min restraint in a 50-ml coni-
cal tube, novel white noise overnight, multiple cage 
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Figure 4. Intergenerational effects of enviromes on organisms: transgenerational latent early-life associated 
regulation. A simple one-generation pedigree is presented, in which the maternal envirome (EnviromeM) acts 
upon the initial maternal parent (OrganismM0) any number of times until time of reproduction/parturition 
(OrganismMn), at which it makes its genetic and epigenetic contributions to the offspring (OrganismF0). The 
paternal counterparts (EnviromeP, OrganismP0 and OrganismPn) likewise contribute in a similar fashion. Although 
not shown, the maternal contribution includes additional material, such as mitochondria, which would also 
be subject to environmental influence. The offspring, from conception, is then affected by the filial envirome 
(EnviromeF), which would include prenatal and perinatal conditions. Ultimately, this would give rise to the 
offspring at time ‘n’ (OrganismFn), which could suffer a neuropathological condition. Although presented as 
distinct, the various enviromes can easily overlap to greater or lesser degree, and envirome–organism interactions 
are a multiple events.
EnviromeM
OrganismM0
OrganismMN OrganismPn
OrganismF0
OrganismFn
OrganismP0
EnviromeP
EnviromeF
future science group
Special Report    Lahiri, Maloney, Bayon et al.
changes and water-saturated bedding overnight can 
lead to dysmasculanization in the male offspring that 
recurs for several generations, and this is transmitted 
from the prenatally stressed males through their male 
offspring [111]. In adult male rats, increased anxiety, 
abnormal behavior and elevated corticosteroid levels 
were observed in both male and female offsprings of 
male mice after these mice underwent chronic social 
defeat paradigm. All offsprings were sired by in vitro 
fertilization. This permitted sperm to be collected 
from the defeat-exposed sires both before and after 
their exposure. Offspring from postdefeat-exposed 
sires had higher levels of anxiety/abnormal behavior 
and corticosteroids both in comparison to the same 
sires (predefeat) and no-exposed sires [112].
The role of these epigenetic changes on social behav-
ior is critical for the understanding of these traits across 
generations, especially as related to disorders such as 
ASD and schizophrenia. These changes may also highly 
influence parenting style choices of mothers for future 
generations. Germline effects have been observed in 
fathers, hinting to their role in transmitting influence 
epigenetically to their offspring perhaps making up for a 
lack of parental care and influence often provided by the 
mother [113]. Transmission of gestational programming 
effects occurs in subsequent generations in the absence 
of continued adverse environmental exposures [114]. 
For example, the ‘Dutch Famine’ (1944–1945) cohort 
showed that prenatal exposure to famine resulted in 
hypomethylation of IGF2 gene in whole blood, and 
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hypermethylation of two obesity-related nonimprinted 
genes (tumor necrosis factor, leptin) compared with 
same-sex siblings who had not been exposed to the 
famine [115,116]. In addition, increased adiposity was 
observed in the offspring of prenatally undernourished 
fathers from that cohort [117]. Understanding the mech-
anism of how traits are maintained and transmitted in 
the germline is the key to developing strategies to pre-
vent environmental exposures from producing a disease 
phenotype across generations.
 Executive summary
Genomic variations
•	 Small variants, copy number variants and rare variants do not add up to explain the cases of sporadic diseases.
•	 Most SNPs have little clinical value.
•	 Copy number variants and other structural variants contribute to genetic variation, and they are frequently 
found in both healthy people and those with ‘sporadic’ diseases.
•	 Rare genetic variants do not provide an explanation of over 90% cases of bipolar disorder, schizophrenia, or 
autism spectrum disorder.
•	 Genetic models can be greatly supported and expanded by explicit mechanistic explanations of 
gene–environment interaction.
Genetic variation on its own does not explain all pathogenesis of ‘sporadic’ disorders
•	 In many disorders with known genetic components, such as Alzheimer’s disease, cases that can be explained 
solely by genetic mutation are a minor fraction.
•	 There is an important role played by epigenomic factors in conditions as diverse as Alzheimer’s disease, 
Parkinson’s disease, schizophrenia and even suicide.
•	 Epigenomic markers include modifications of DNA and of chromatin histones.
•	 Epigenomic contributions to neurobiological disorders may actually reach across generations.
Latent early-life associated regulation unites environment & gene expression
•	 For many sporadic disorders, the body accumulates ‘hits’ (that may include some genetic predispositions).
•	 No single hit is sufficient to cause disease.
•	 Each is individually latent.
•	 Many hits are of environmental origin and are ‘recorded’ in the organism through epigenomic markers.
•	 If a sufficient number of ‘correct’ hits occur before a critical developmental/aging threshold, the organism will 
develop the corresponding disorder
A model uniting environment, organism & generations: transgenerational latent early-life associated 
regulation
•	 In interaction with the environment, an organism exists on two levels.
•	 These are the information-coding and transmitting molecules and an information network that ‘resides’ in the 
‘media’ of the molecules.
•	 An organism can also be seen as the substrate of the envirome.
•	 extends this across generations.
•	 Changes in brain function, such as aversion to acetophenone, can be due to transgenerational epigenetic 
transmission. In autism, for example, low paternal folate in diet, paternal age, grand paternal age and 
paternal obesity but not maternal obesity contribute to risk.
Evidence for intergenerational transmission of traits via epigenetics
•	 Exposures induce permanent epigenetic changes in the germline.
•	 Heritable changes lead to adult-onset disease in subsequent generations without further exposure to insult.
•	 This can apply to behavioral disorders, such as addiction and resistance to addiction.
•	 Mouse studies show that exposure of parents to environmental factors can have a profound effect on the 
changes in insulin sensitivity seen in Type 2 diabetes in offspring.
•	 The experiences of one generation can alter the behavior of subsequent offspring.
•	 Experience of maternal separation during early development altered DNA methylation levels in the brains and 
sperm of offspring and grandoffspring.
Conclusion & future perspective: research & treatment with transgenerational latent early-life associated 
regulation
•	 A longitudinal epigenome/envirome-wide association study would unite genetic sequence, epigenomic 
markers, environmental exposures, patient personal history at multiple time points and family history.
•	 Cohorts would include representatives of at least two generations, preferably more.
•	 The possibility exists that, should environmentally induced, inherited epigenomic ‘mis-markings’ increase risk 
for disorders in offspring, supplementing diet while avoiding repeating parental exposures may permanently 
reduce inherited risk.
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Conclusion & future perspective: research  
& treatment based on the tLEARn concept
Testing tLEARn will require longitudinal, synthetic 
approaches. GWAS are end point assays that compare 
genetic sequences between diseased and nondiseased 
individuals. Several assays currently exist, which 
address parts of the question, but none consider the 
whole picture, particularly not in relation to changes 
over time. A longitudinal epigenome/envirome-wide 
association study (LEWAS) would unite genetic 
sequence, epigenomic markers, environmental expo-
sures, patient personal history taken at multiple time 
points and family history. Ideally, cohorts would 
include representatives of at least two generations, 
preferably more. Several studies have partially imple-
mented the LEWAS concept. Mouse studies have 
measured changes in specific gene-associated epi-
genetic changes to environment and concomitant 
changes in expression for those specific genes [118–120]. 
Targeted epigenomic surveys have been performed 
on human populations, comparing ‘end point’ differ-
ences in epigenomic markers and disease [63,121–123]. 
However, no study method currently unites multiple 
measurements over time with human populations 
and an envirome/organism-wide approach. Large-
scale epigenomic surveys are currently underway, 
but these are end point, focused, without tracking 
changes in the epigenome [124,125]. The novel element 
of LEWAS is its longitudinal approach, attempting 
to measure, rather than infer post hoc, disease-crit-
ical organismal changes and relates those to previ-
ous environmental influences. LEWAS poses chal-
lenges in terms of scope and cost, particularly the 
need for large sample sizes in the face of unknown 
later development of disease and multiple sampling 
times. Multiple longitudinal studies have been done 
or are ongoing for conditions such as AD [126–129], 
PD [130,131], ASD [132–134], bipolar disorder [135,136], 
psychotic disorders [10,137] and other conditions [137], 
although not all are biochemical or epigenetic stud-
ies. Modern communication (especially the advent of 
social media and internet-based rating systems) has 
made these studies far more feasible than in the past. 
Methods exist to begin studies with very large sample 
sizes and reduce them to a ‘hypothesis relevant’ sub-
sample [138]. For disorders of the CNS or other vital 
organs, direct sampling will not be possible. How-
ever, proxy tissues may be developed. For example, 
olfactory neuroepithelial cells are easily accessed and 
can be repeatedly sampled with safety. These have 
been adequate proxies for other neurological stud-
ies [139]. Also stem cell technology has advanced such 
that neuronal cells may be developed that reflect the 
genetic (and possibly epigenetic) characteristics of 
the donor. These can be modified with CRISPR-Cas 
9-based methods.
Of course, one exciting possibility of tracing epig-
enomic antecedents to disorders is new treatment 
avenues, including the possibility of treatments that 
may not need to be lifelong. In particular, aber-
rant hypomethylation of DNA could potentially be 
reversed and this reversal could be maintained by 
means of avoiding high level or chronic exposures 
to materials such as pesticides and by eating a diet 
rich in materials like S-adenosyl-methionine (SAM). 
Dietary SAM supplementation via apple juice con-
centrate has been shown to reverse aberrant hypo-
methylation in AD-model mice [140]. Likewise, such 
supplementation also reversed cognitive deficits and 
reoriented DNA methylation in dietary-induced 
DNA hypomethylated mice [141]. It is worthwhile to 
explore the possibility that if specific environmen-
tally-induced, inherited, epigenomic ‘mis-markings’ 
increase risk for sporadic disorders in offspring, 
perhaps supplementing diet while avoiding repeat-
ing parental exposures could permanently reduce 
inherited risk. Other ongoing studies exploring the 
epigenetics of dementias would provide potential 
preventative and therapeutic strategies [141]. Finally, 
as manifestations of the gut influence on behavior 
and diseases are beginning to be understood, future 
directions would further investigate the influence of 
gut microbiota [142] on tLEARn.
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